Exact Mass: 348.2413
Exact Mass Matches: 348.2413
Found 500 metabolites which its exact mass value is equals to given mass value 348.2413
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
dihydrocorticosterone
3a,21-Dihydroxy-5b-pregnane-11,20-dione
3alpha,21-Dihydroxy-5beta-pregnane-11,20-dione is an intermediate in C21-Steroid hormone metabolism. 3alpha,21-Dihydroxy-5beta-pregnane-11,20-dione is converted from Tetrahydrocorticosterone via the enzyme 11beta-hydroxysteroid dehydrogenase (EC 1.1.1.146). It is then converted to 3alpha,20alpha,21-Trihydroxy-5beta-pregnane-11-one via the enzyme 3alpha(or 20beta)-hydroxysteroid dehydrogenase (EC 1.1.1.53). 3alpha,21-Dihydroxy-5beta-pregnane-11,20-dione is an intermediate in C21-Steroid hormone metabolism. 3alpha,21-Dihydroxy-5beta-pregnane-11,20-dione
17alpha,21-Dihydroxypregnenolone
17alpha,21-Dihydroxypregnenolone is an intermediate in the human fetus at midpregnancy that is converted into cortisol (PMID: 4231965). It has also been found as an intermediate in alternative pathways in human adrenal steroidogenesis that take place under in vitro conditions. In normal adrenal slices from patients with hypernephroid kidney carcinomas these pathways bypass cholesterol, pregnenolone, and progesterone, and proceed to 21-hydroxypregnenolone (PMID: 6247575). 17alpha,21-Dihydroxypregnenolone is an intermediate in C21-Steroid hormone metabolism. 17alpha,21-Dihydroxypregnenolone is the 5th to last step in the synthesis of Cortol and is converted from 17alpha-Hydroxypregnenolone via the enzyme cytochrome P450 (EC 1.14.99.10). It is then converted to 11beta,17alpha,21-Trihydroxypregnenolone via the enzyme cytochrome P450 (EC 1.14.15.4). 17alpha,21-Dihydroxypregnenolone is an intermediate in C21-Steroid hormone metabolism. 17alpha,21-Dihydroxypregnenolone is the 5th to last step in the synthesis of Cortol and is converted from 17alpha-Hydroxypregnenolone via the enzyme cytochrome P450 (EC 1.14.99.10). It is then converted to 11beta,17alpha,21-Trihydroxypregnenolone via the enzyme cytochrome P450 (EC 1.14.15.4). [HMDB] D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
11b,21-Dihydroxy-5b-pregnane-3,20-dione
11beta,21-Dihydroxy-5beta-pregnane-3,20-dione is an intermediate in C21-Steroid hormone metabolism. 11beta,21-Dihydroxy-5beta-pregnane-3,20-dione is the 3rd to last step in the synthesis of 3alpha,20alpha,21-Trihydroxy-5beta-pregnane-11-one and is converted from Corticosterone via the enzyme 3-oxo-5beta-steroid 4-dehydrogenase (EC 1.3.99.6). It is then converted to Tetrahydrocorticosterone via the enzyme 3-alpha-hydroxysteroid dehydrogenase (EC 1.1.1.50). [HMDB] 11beta,21-Dihydroxy-5beta-pregnane-3,20-dione is an intermediate in C21-Steroid hormone metabolism. 11beta,21-Dihydroxy-5beta-pregnane-3,20-dione is the 3rd to last step in the synthesis of 3alpha,20alpha,21-Trihydroxy-5beta-pregnane-11-one and is converted from Corticosterone via the enzyme 3-oxo-5beta-steroid 4-dehydrogenase (EC 1.3.99.6). It is then converted to Tetrahydrocorticosterone via the enzyme 3-alpha-hydroxysteroid dehydrogenase (EC 1.1.1.50).
Oxyphenonium
A quaternary ammonium anticholinergic agent with peripheral side effects similar to those of atropine. It is used as an adjunct in the treatment of gastric and duodenal ulcer, and to relieve visceral spasms. The drug has also been used in the form of eye drops for mydriatic effect. [PubChem] A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics
[10]-Gingerdione
[10]-Gingerdione is found in herbs and spices. [10]-Gingerdione is isolated from Zingiber officinale (ginger
9alpha-(3-Methyl-2E-pentenoyloxy)-4S-hydroxy-10(14)-oplopen-3-one
9alpha-(3-Methyl-2E-pentenoyloxy)-4S-hydroxy-10(14)-oplopen-3-one is found in tea. 9alpha-(3-Methyl-2E-pentenoyloxy)-4S-hydroxy-10(14)-oplopen-3-one is a constituent of Tussilago farfara (coltsfoot). Constituent of Tussilago farfara (coltsfoot). 9alpha-(3-Methyl-2E-pentenoyloxy)-4S-hydroxy-10(14)-oplopen-3-one is found in tea.
[8]-Paradyl acetate
[8]-Paradyl acetate is found in alcoholic beverages. [8]-Paradyl acetate is a constituent of Amomum melegueta (grains of paradise). Constituent of Amomum melegueta (grains of paradise). [8]-Paradyl acetate is found in alcoholic beverages and herbs and spices.
3b,15b,17a-Trihydroxy-pregnenone
3b,15b,17a-Trihydroxy-pregnenone is a major 15 beta-hydroxylated metabolite unique to the human perinatal period. (PMID 8750436). The chemical synthesis of 15β-hydroxylated steroids is for use in the (a) development of new immunoassay techniques for application to newborn screening programs and fetal well-being; (b) development of new anti-androgenic drugs; and (c) study of androgen/estrogen interaction in late pregnancy.
7'-Carboxy-alpha-chromanol
7-carboxy-alpha-tocopherol is a dehydrogenation carboxylate product of 7-hydroxy-a-tocopherol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate. The tocopherols ( a-tocopherol , b-tocopherol ,r-tocopherol and d-tocopherol ) and their corresponding tocotrienols are synthesized by plants and have vitamin E antixoidant activity (see pathway vitamin E biosynthesis ). They differ in the number and location of methyl groups on the chromanol ring. The naturally occurring form of a-tocopherol is (2R,4R,8R)-a-tocopherol (synonym (R,R,R)-a-tocopherol). Synthetic a-tocopherols are a racemic mixture of eight different R and S stereoisomers. Only the 2R forms are recognized as meeting human requirements. The in vivo function of vitamin E is to scavenge peroxyl radicals via its phenolic (chromanol) hydroxyl group, thus protecting lipids against free radical-catalyzed peroxidation. The tocopheryl radical formed can then be reduced by reductants such as L-ascorbate. Other major products of a-tocopherol oxidation include α-tocopherylquinone and epoxy-a-tocopherols. The metabolites a-tocopheronic acid and its lactone, known as the Simon metabolites, are generally believed to be artefacts. In addition to these oxidation products, the other major class of tocopherol metabolites is the carboxyethyl-hydroxychromans.These metabolites are produced in significant amounts in response to excess vitamin E ingestion. Vitamin E is fat-soluble and its utilization requires intestinal fat absorption mechanisms. It is secreted from the intestine into the lymphatic system in chylomicrons which subsequently enter the plasma. Lipolysis of these chylomicrons can result in delivery of vitamin E to tissues, transfer to high-density lipoproteins (and subsequently to other lipoproteins via the phospholipid exchange protein), or retention in chylomicron remnants. These remnants are taken up by the liver. Natural (R,R,R)-α-tocopherol and synthetic 2R-α-tocopherols are then preferentially secreted from the liver into plasma as a result of the specificity of the α-tocopherol transfer protein. This protein, along with the metabolism of excess vitamin E in the liver and excretion into urine and bile, mediate the supply of a-tocopherol in plasma and tissues. 7-carboxy-alpha-tocopherol is a dehydrogenation carboxylate product of 7-hydroxy-a-tocopherol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate
17,20,21-Trihydroxypregn-4-en-3-one
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Alfadolone
(Z)-7-[(1R,4S,5R,6R)-5-[(E,3S)-3-Hydroxyoct-1-enyl]-2,3-diazabicyclo[2.2.1]hept-2-en-6-yl]hept-5-enoic acid
Deoxycortisol
17,21-Dihydroxypregnane-3,20-dione
trihydroxy-4-pregnen-3-one
Sativic acid
Sativic acid, also known as sativate, is a member of the class of compounds known as long-chain fatty acids. Long-chain fatty acids are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Thus, sativic acid is considered to be an octadecanoid lipid molecule. Sativic acid is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Sativic acid can be found in rice, which makes sativic acid a potential biomarker for the consumption of this food product.
10-Gingerdione
10-gingerdione is a member of the class of compounds known as methoxyphenols. Methoxyphenols are compounds containing a methoxy group attached to the benzene ring of a phenol moiety. 10-gingerdione is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 10-gingerdione can be found in ginger, which makes 10-gingerdione a potential biomarker for the consumption of this food product.
Methyl ent-16-hydroxy-6-oxo-7,13E-labdadien-15-oate
2beta-Hydroxy-1alpha-hydroxymethylcolensene-2alpha-carboxylic acid lactone
Methyl 15-hydroperoxy-8alpha,12alpha-epioxiabiet-13-en-19-oate
(1S,4aR,5S)-5-[(3E)-5-Methoxy-3-methyl-5-oxo-3-penten-1-yl]-1,4a-dimethyl-6-methylenedecahydro-1-naphthalenecarboxylic acid
Monomethyl kolavate
Monomethyl kolavate is a natural product found in Prioria balsamifera with data available.
11b,21-Dihydroxy-5b-pregnane-3,20-dione
11beta,21-Dihydroxy-5beta-pregnane-3,20-dione is an intermediate in C21-Steroid hormone metabolism. 11beta,21-Dihydroxy-5beta-pregnane-3,20-dione is the 3rd to last step in the synthesis of 3alpha,20alpha,21-Trihydroxy-5beta-pregnane-11-one and is converted from Corticosterone via the enzyme 3-oxo-5beta-steroid 4-dehydrogenase (EC 1.3.99.6). It is then converted to Tetrahydrocorticosterone via the enzyme 3-alpha-hydroxysteroid dehydrogenase (EC 1.1.1.50). [HMDB] 11beta,21-Dihydroxy-5beta-pregnane-3,20-dione is an intermediate in C21-Steroid hormone metabolism. 11beta,21-Dihydroxy-5beta-pregnane-3,20-dione is the 3rd to last step in the synthesis of 3alpha,20alpha,21-Trihydroxy-5beta-pregnane-11-one and is converted from Corticosterone via the enzyme 3-oxo-5beta-steroid 4-dehydrogenase (EC 1.3.99.6). It is then converted to Tetrahydrocorticosterone via the enzyme 3-alpha-hydroxysteroid dehydrogenase (EC 1.1.1.50).
17alpha,21-Dihydroxypregnenolone
17alpha,21-Dihydroxypregnenolone is an intermediate in the human fetus at midpregnancy that is converted into cortisol (PMID: 4231965). It has also been found as an intermediate in alternative pathways in human adrenal steroidogenesis that take place under in vitro conditions. In normal adrenal slices from patients with hypernephroid kidney carcinomas these pathways bypass cholesterol, pregnenolone, and progesterone, and proceed to 21-hydroxypregnenolone (PMID: 6247575). 17alpha,21-Dihydroxypregnenolone is an intermediate in C21-Steroid hormone metabolism. 17alpha,21-Dihydroxypregnenolone is the 5th to last step in the synthesis of Cortol and is converted from 17alpha-Hydroxypregnenolone via the enzyme cytochrome P450 (EC 1.14.99.10). It is then converted to 11beta,17alpha,21-Trihydroxypregnenolone via the enzyme cytochrome P450 (EC 1.14.15.4). 17alpha,21-Dihydroxypregnenolone is an intermediate in C21-Steroid hormone metabolism. 17alpha,21-Dihydroxypregnenolone is the 5th to last step in the synthesis of Cortol and is converted from 17alpha-Hydroxypregnenolone via the enzyme cytochrome P450 (EC 1.14.99.10). It is then converted to 11beta,17alpha,21-Trihydroxypregnenolone via the enzyme cytochrome P450 (EC 1.14.15.4). [HMDB] D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
3-deoxyaulacocarpin A|methyl 8beta,17:14xi,15-diepoxy-12(E)-labden-16-oate
(3R)-3,4-dihydro-8-hydroxy-6-methoxy-3-undecyl-1H-[2]benzopyran-1-one|(3R)-8-hydroxy-6-methoxy-3-undecyl-3,4-dihydroisocoumarin|6-Me ether-(R)-3,4-Dihydro-6,8-dihydroxy-3-undecyl-1H-2-benzopyran-1-one|8-hydroxy-6-methoxy-3-undecyl-3,4-dihydroisocoumarin
11beta,17alpha,20beta-Trihydroxy-3-keto-Delta4-pregnen|Delta4-Pregnentriol-(11beta,17alpha,20beta)-on-(3)
3,17-Dioxo-8beta-H-ent-labda-13z-en-15-saeuremethylester
3beta,14,15alpha-Trihydroxy-14beta-pregn-5-en-20-on|3beta,14,15alpha-trihydroxy-14beta-pregn-5-en-20-one|Purpuigenin
(2beta,3alpha,4beta,5beta)-2,3,4-Trihydroxypregn-16-en-20-one|2beta,3alpha,4beta-Trihydroxy-5beta-pregn-16-en-20-on
(3S,5S,8R,9R,10S)-3-acetoxy-9,13-epoxy-16-norlabda-13E-en-15-al|negundoin C
ceriopsin A|methyl 17-hydroxy-16-oxo-beyeran-18-oate
methyl 15,16-epoxy-6-alpha-hydroxycleroda-3,13-dien-18-oate
13alpha-methoxy-7-oxo-8(14)-abieten-18-oic acid|abiesadine T
3beta, 12beta, 14-Trihydroxy-14beta-pregn-5-en-20-one|3beta,12beta,14-Trihydroxy-14beta-pregn-5-en-20-on|3beta,12beta,14-trihydroxy-14beta-pregn-5-en-20-one|digipurpurogenin II|isoramanone
17alpha,20R-dihydroxypregnan-3,16-dione|17??,20R-Dihydroxypregnan-3,16-dione
methyl 14xi,15-epoxy-3beta-hydroxy-8(17),12(E)-labdadien-16-oate
Cheloviolene E|seco-norrisolide B|Seconorrlandin B
(Z)-2,5-dihydroxy-3-(pentadec-8-enyl)-1,4-benzoquinone
3alpha(3-Methylpent-2c-enoyloxy)-9alpha-hydroxy-eremophil-8-on-11(12)en
12,16-epoxy-5alpha-hydroxy-12alpha-methoxycassa-13(15)-en-16-one|neocaesalpin E
9alpha-(3-Methyl-pent-3-enoyloxy)-8alpha-hydroxy-2-oxo-10beta-H-eremophil-11(12)en
9alpha,13alpha-epoxy-8-oxo-9(8->7)abeo-7betaH-abietan-18-oic acid methyl ester|larikaempferic acid methyl ester
(3beta,15beta,17alphaOH)-3,15,17-Trihydroxypregn-5-en-20-one
(1S*,4S*,9R*,11S*)-15-acetoxy-16-norxeniaphylla-8(19)-en-5,12-dione|gibberosin O
Formyl-(ent-13E)-15-Hydroxy-1(10),13-halimadien-18-oic acid
2,19-oxymeliavosin|2alpha,3beta-dihydroxypregnan-16-one 2beta,19-hemiketal
3Beta-acetoxy-11beta-hydroxy-5beta-androstan-17-one
ent-3,15,16-trihydroxypimar-8(14)-en-15,16-acetonide
16,17-Dihydroxy-9(11)-kauren-18-saeure-methylester|methyl 16,17-dihydroxy-ent-kaur-9(11)-en-19-oate|methyl ent-16beta,17-dihydroxy-9(11)-kauren-19-oate|methyl-16alpha,17-dihydroxy-16,17-dihydro-9(11)-dehydro-ent-kaurenoate
3-Ac-(3beta,5alpha,13alpha,16alpha)-3,16-Dihydroxyandrostan-17-one
(3alpha,17alphaOH)-3,17-Dihydroxypregnane-1,20-dione
l-prostaglandin B2 methyl ester|methyl (5Z,13E,15S)-15alpha-hydroxy-9-oxoprosta-5,8(12),13-trien-1-oate|Prostaglandin-B(2)-methylester
(-)-(1S*,4R*,10R*)-1-hydroxy-4-methoxycembra-2E,7E,11Z-trien-20,10-olide
12(S)-hydroxy-15xi-methoxy-labdan-8(17),13(14)-dien-15,16-olide
16,17-dihydroxy-18(4->3)-abeo-ent-kaur-3-en-18-oic acid methyl ester|methyl ent-16,17-dihydroxy-18-norkaur-3-ene-3-carboxylate|methyl pothoscandensate
(1S,4E,4aS,9R,11aR)-1,3,4,4a,5,6,9,10,11,11a-decahydro-4-[(2E)-4-methoxy-4-methylpent-2-en-1-ylidene]-7-methyl-11-methylidenecyclonona[c]pyran-1,9-diol|asterolaurin K
methyl 4alpha-formylgrindelate|methyl-18-oxo-grindeloate
(1R,3S,3aR,6R,10aS)-3,3a,4,5,6,9,10,10a-octahydro-1-(hydroxymethyl)-3-methoxy-8-methyl-4-methylidene-1-[(1E)-4-methylpenta-1,3-dien-1-yl]-1H-cyclonona[c]furan-6-ol|asterolaurin M
methyl ent-7alpha,15beta-dihydroxy-kaur-16-en-19-oate
ent-15beta,16beta-epoxy-17-hydroxykauran-19-oic acid
(3alpha,7beta,14beta,20xi)-3,7,20-Trihydroxypregn-4-en-15-one
3beta,11,19-trihydroxy-14-methoxy-abieta-8,11,13-triene
14,14O-dihydro(14beta)-13beta-methoxysarcodonin G|neosarcodonin A
(6aR,9S,10S,10aR)-9,10-Dihydroxyhexahydrocannabinol (Cannabiripsol)
ceriopsin F|methyl ent-13,17-epoxy-16-hydrokauran-19-oate
methyl 10(S*)-acetoxy-6(Z),8(E),12(Z),15(Z)-octadecatetraenoate
17-Me ether-17, 18-Epoxy-1(19), 7, 10, 12-xenicatetraene-6, 14, 17-triol
(5beta,7beta,15beta)-7,15-Dihydroxypregnane-3,20-dione
18,19-epoxy-18alpha-methoxy-ent-cleroda-3,13E-dien-15-oic acid
methyl 13xi,14xi-epoxy-15-oxo-labd-8(17)-en-19-oate
(2R)-2-[(3aR,7aR)-3-Oxo-5-[(1S)-1,3,3-trimethylcyclohexyl]-1,3,3a,6,7,7a-hexahydroisobenzofuran-4-yl]propanoic acid methyl ester
methyl-7-oxo-9beta,13beta-epoxy-ent-labd-14-en-18-oate
methyl (5Z,13E,15S)-15-hydroxy-9-oxo-prosta-5,8(12),13-trien-1-oate
methyl ent-9alpha,15beta-dihydroxy-kaur-16-en-19-oate|methyl-9beta-hydroxygrandiflorate
methyl ent-12-hydroxy-16-oxolabda-7,13Z-dien-15-oate
3-Methyl-2-butenoyl,Me ester-2alpha-2-Hydroxy-4(15),11(13)-eudesmadien-12-oic acid
methyl-2beta-(2-methylbutyryloxy)-delta-cadinene-15-oate
C21H32O4_(5beta,8alpha,9beta,10alpha,13alpha)-18-Methoxy-18-oxokauran-17-oic acid
C21H32O4_1-Naphthalenecarboxylic acid, decahydro-5-[(3E)-5-methoxy-3-methyl-5-oxo-3-penten-1-yl]-1,4a-dimethyl-6-methylene-, (1S,4aR,5S)
C21H32O4_2-{4a-Methyl-8-methylene-4-[(3-methylpentanoyl)oxy]decahydro-2-naphthalenyl}acrylic acid
2-[4a-methyl-8-methylidene-4-(3-methylpentanoyloxy)-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl]prop-2-enoic acid
(1S,4aR,5S)-5-[(E)-5-methoxy-3-methyl-5-oxopent-3-enyl]-1,4a-dimethyl-6-methylidene-3,4,5,7,8,8a-hexahydro-2H-naphthalene-1-carboxylic acid
(4aS,5R,6S,8aS)-5-[(E)-5-methoxy-3-methyl-5-oxopent-3-enyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid
2-[4a-methyl-8-methylidene-4-(3-methylpentanoyloxy)-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl]prop-2-enoic acid_81.3\\%
2-[4a-methyl-8-methylidene-4-(3-methylpentanoyloxy)-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl]prop-2-enoic acid_major
(1S,4aR,5S)-5-[(E)-5-methoxy-3-methyl-5-oxopent-3-enyl]-1,4a-dimethyl-6-methylidene-3,4,5,7,8,8a-hexahydro-2H-naphthalene-1-carboxylic acid_major
(4aS,5R,6S,8aS)-5-[(E)-5-methoxy-3-methyl-5-oxopent-3-enyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid_major
2-[4a-methyl-8-methylidene-4-(3-methylpentanoyloxy)-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl]prop-2-enoic acid_65.4\\%
(1S,4aR,5S)-5-[(E)-5-methoxy-3-methyl-5-oxopent-3-enyl]-1,4a-dimethyl-6-methylidene-3,4,5,7,8,8a-hexahydro-2H-naphthalene-1-carboxylic acid_2.2\\%
3b,15b,17a-Trihydroxy-Pregnenone
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
methyl 6-hydroperoxy-4,8,11,14,17-eicosapentaenoate
methyl 8-hydroperoxy-5,9,11,14,17-eicosapentaenoate
methyl 9-hydroperoxy-5,7,11,14,17-eicosapentaenoate
methyl 11-hydroperoxy-5,8,12,14,17-eicosapentaenoate
Methocidin
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics
9alpha-(3-Methyl-2E-pentenoyloxy)-4S-hydroxy-10(14)-oplopen-3-one
(4aS,5R,6S,8aS)-5-[(3E)-5-Methoxy-3-methyl-5-oxo-3-penten-1-yl]-5,6,8a-trimethyl-3,4,4a,5,6,7,8,8a-octahydro-1-naphthalenecarboxylic acid
ST 21:2;O4
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
(S)-2-(DIBENZYLAMINO)-5-(1H-PYRROL-1-YL)PENTAN-2-OL
6-(tert-Butyloxycarbonyl-methylamino)-5-methylpyridine-3-boronic acid pinacol ester
(8R,9S,10R,13S,14S,17R)-17-[(1R)-1,2-dihydroxyethyl]-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
tert-Butyl 2-((3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)amino)acetate
1,2-Difluoro-4-[trans-4-[2-(trans-4-propylcyclohexyl)ethyl]cyclohexyl]-benzene
1,2-Difluoro-4-[2-[(trans,trans)-4-propyl[1,1-bicyclohexyl]-4-yl]ethyl]benzene
tert-Butyl 4-(4-amino-5-isopropoxy-2-methylphenyl)piperidine-1-carboxylate
Benzene, 1-[(trans,trans)-4-ethenyl[1,1-bicyclohexyl]-4-yl]-4-ethoxy-2,3-difluoro-
Iferanserin
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Iferanserin (S-MPEC) is a selective 5-HT receptor (serotonin receptor) antagonist with an affinity for 5-HT2A receptor. Iferanserin has the potential for internal hemorrhoid disease treatment[1].
(3-Exo)-3-(10,11-Dihydro-5h-Dibenzo[a,D][7]annulen-5-Yloxy)-8,8-Dimethyl-8-Azoniabicyclo[3.2.1]octane
(Z)-7-[(1R,2R,5S)-5-hydroxy-3-methylidene-2-[(E)-3-oxooct-1-enyl]cyclopentyl]hept-5-enoic acid
5-(5-Methoxy-3-methyl-5-oxopent-3-enyl)-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid
(1E,3R,10R,11S)-9,14-dihydroxy-14-(methoxymethyl)-3,10-dimethyl-6-propan-2-yltricyclo[9.3.0.03,7]tetradeca-1,6-dien-5-one
(5Z)-5-[4-[(E)-3-cyclopentyl-3-hydroxyprop-1-enyl]-5-hydroxy-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid
10,13-Dimethyl-17-(2,2,2-trihydroxyethyl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
(Z)-7-[(1R,4S,5R,6R)-5-[(E,3S)-3-Hydroxyoct-1-enyl]-2,3-diazabicyclo[2.2.1]hept-2-en-6-yl]hept-5-enoic acid
[3-Carboxy-2-(3,8-dihydroxydecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(3,6-dihydroxydecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(3,4-dihydroxydecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(3,9-dihydroxydecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(3,7-dihydroxydecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(3,5-dihydroxydecanoyloxy)propyl]-trimethylazanium
rel-(-)-(1S,4R,10R)-1-hydroxy-4-methoxycembra-2E,7E,11Z-trien-20,10-olide
A cembrane diterpenoid that is cembra-2E,7E,11Z-trien-20,10-olide substituted by a hydroxy group at position 1 and a methoxy group at position 4. It has been isolated from the leaves of natural product found in Croton gratissimus.
(E)-6-hydroxy-1-(4-hydroxy-3-methoxyphenyl)tetradec-4-en-3-one
(Z)-7-[(1R,4S,5S,6S)-6-[(1E,3S,5Z)-3-hydroxyocta-1,5-dienyl]-2-oxabicyclo[2.2.1]heptan-5-yl]hept-5-enoic acid
9-(2-O-methyl-alpha-L-rhamnosyloxy)nonanehydrazide
2,3-dihydroxypropyl (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
5-[(E)-5-methoxy-3-methyl-5-oxopent-3-enyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid
[1-Carboxy-3-(3-heptanoyloxy-2-hydroxypropoxy)propyl]-trimethylazanium
17alpha,21-Dihydroxypregnenolone
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
5β-dihydrocorticosterone
A 3-oxo-5beta-steroid formed from corticosterone by reduction across the C4-C5 double bond.
5alpha-Dihydrocorticosterone
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Methyl-(10S)-hydroxy-(11S,12S)-epoxy-(5Z,8Z,14Z,17Z)-eicosatetraenoate
Methyl-(10R)-hydroxy-(11S,12S)-epoxy-(5Z,8Z,14Z,17Z)-eicosatetraenoate
2,5,5,8a-tetramethyl-5'-(2-oxoethylidene)-hexahydro-2h-spiro[naphthalene-1,2'-oxolan]-6-yl acetate
(6s)-6-[(1s,3ar,7ar)-6-acetyl-2,3,3a,4,7,7a-hexahydro-1h-inden-1-yl]-6-hydroxy-2-methylhept-1-en-3-yl acetate
methyl (2e)-4-[(1s,4ar,6s,8ar)-6-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-2-[(2r)-oxiran-2-yl]but-2-enoate
methyl 2-{2-formyl-5,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5'-yl}acetate
1-(1-hydroxyethyl)-7-isopropyl-4-methylidene-2-oxo-hexahydro-1h-inden-5-yl 3-methylpent-2-enoate
methyl (6z,8e,10s,12z,15z)-10-(acetyloxy)octadeca-6,8,12,15-tetraenoate
(6s)-3,6-dihydroxy-2-{[(1s,5r)-5-hydroxy-5-methyl-2-[(2r)-6-methylhept-5-en-2-yl]cyclopent-2-en-1-yl]methyl}cyclohex-2-en-1-one
(6e)-11-hydroxy-1-methoxy-10-methyl-6-[(2e)-4-methylpent-2-en-1-ylidene]-4-oxatricyclo[8.3.1.0²,⁷]tetradecan-3-one
(2r)-5-[(1s,4s,6s,10r,12s)-4,12-dimethyl-9-methylidene-5-oxatricyclo[8.2.0.0⁴,⁶]dodecan-12-yl]-5-oxopentan-2-yl acetate
methyl (1r,2s,6r,7s,12r)-12-isopropyl-2,6-dimethyl-13,14-dioxatetracyclo[10.2.2.0¹,¹⁰.0²,⁷]hexadec-10-ene-6-carboxylate
(4bs,8as,9r,10r)-2-isopropyl-3-methoxy-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthrene-4,9,10-triol
(3r,7r,11s)-11-hydroxy-6-[(2r,6s)-7-hydroxy-6-methylheptan-2-yl]-3-methyl-2-oxatricyclo[7.4.0.0³,⁷]trideca-1(9),5-dien-10-one
methyl (3s,8s,8ar)-8-isopropyl-5-methyl-3-{[(2r)-2-methylbutanoyl]oxy}-3,4,6,7,8,8a-hexahydronaphthalene-2-carboxylate
methyl 2-{7-hydroxy-3a,6,6,9a-tetramethyl-2-oxo-octahydrocyclopenta[a]naphthalen-3-ylidene}propanoate
methyl 2-[(1s,4as,5's,8as)-2-formyl-5,5,5',8a-tetramethyl-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5'-yl]acetate
(2s,4as,7r,8ar)-7-[(2r)-1-methoxy-1-oxopropan-2-yl]-4a-methyl-1-methylidene-octahydronaphthalen-2-yl (2e)-2-methylbut-2-enoate
methyl (1s,4as,5r,6r,8as)-5-[2-(furan-3-yl)ethyl]-6-(hydroxymethyl)-1,4a-dimethyl-octahydronaphthalene-1-carboxylate
methyl 2-[(1s,3r,5e,7s,10e,14s)-7-hydroxy-6,10,14-trimethyl-15-oxabicyclo[12.1.0]pentadeca-5,10-dien-3-yl]prop-2-enoate
2-hydroxy-4a,5-dimethyl-7-oxo-3-(prop-1-en-2-yl)-octahydronaphthalen-1-yl 3-methylpent-2-enoate
(2s,4as,7r,8ar)-7-[(2r)-1-methoxy-1-oxopropan-2-yl]-4a-methyl-1-methylidene-octahydronaphthalen-2-yl 3-methylbut-2-enoate
5-(5-methoxy-3-methyl-5-oxopent-3-en-1-yl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid
13-hydroxy-6-(2-hydroxy-6-methylhept-5-en-2-yl)-3-methyl-2-oxatricyclo[7.4.0.0³,⁷]tridec-1(9)-en-10-one
methyl (1s,4as,4br,8as)-8a-hydroxy-7-isopropyl-1,4a-dimethyl-6-oxo-2,3,4,4b,5,9,10,10a-octahydrophenanthrene-1-carboxylate
methyl 4-(6-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)-2-(oxiran-2-yl)but-2-enoate
(6s)-3,6-dihydroxy-2-{[(1r,5s)-5-hydroxy-5-methyl-2-[(2s)-6-methylhept-5-en-2-yl]cyclopent-2-en-1-yl]methyl}cyclohex-2-en-1-one
methyl 5-[2-(2,5-dihydrofuran-3-yl)ethyl]-8-hydroxy-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylate
1-[(1s,3as,3br,7s,9br,11r,11as)-3a,7,11-trihydroxy-3b,11a-dimethyl-1h,2h,3h,4h,6h,7h,8h,9h,9ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethanone
(1r,4ar,4br,7s,10ar)-7-hydroxy-7-isopropyl-1,4a,10a-trimethyl-9-oxo-3,4,4b,5,6,10-hexahydro-2h-phenanthrene-1-carboxylic acid
(1r,2s,3s,4r,7s,10s,11r)-3,11-dihydroxy-1-methoxy-10-methyl-4-(2-methylprop-1-en-1-yl)tricyclo[8.3.1.0²,⁷]tetradec-5-ene-6-carbaldehyde
1-[4-hydroxy-7-(3-methylbut-2-en-1-yl)-1,3-dihydro-2-benzofuran-1-yl]octane-2,3-diol
methyl 2-[(1s,3r,7s,14s)-7-hydroxy-6,10,14-trimethyl-15-oxabicyclo[12.1.0]pentadeca-5,10-dien-3-yl]prop-2-enoate
({5-hexyl-7-oxo-decahydropyrrolo[2,1-j]quinolin-3-yl}methyl)sulfanylcarbonitrile
(4r)-3,4-dihydroxy-2-{[(1s,2s,5r)-2-hydroxy-2-methyl-5-[(2e)-6-methylhepta-2,5-dien-2-yl]cyclopentyl]methyl}cyclohex-2-en-1-one
(1s,2r,3r,4ar,5s,8as)-2-hydroxy-4a,5-dimethyl-7-oxo-3-(prop-1-en-2-yl)-octahydronaphthalen-1-yl (3e)-3-methylpent-3-enoate
(6ar,7s,8r,10as)-7-{2-[(3s,5s)-5-methoxyoxolan-3-yl]ethyl}-7,8-dimethyl-1h,5h,6h,6ah,8h,9h,10h-naphtho[4,4a-c]furan-3-one
methyl (3s,8s,8ar)-8-isopropyl-5-methyl-3-[(3-methylbutanoyl)oxy]-3,4,6,7,8,8a-hexahydronaphthalene-2-carboxylate
methyl (1s,4s,5r,9r,10r,13r,15s)-10,15-dihydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate
(2e)-5-[(1r,4ar,8as)-2,5,5,8a-tetramethyl-4-oxo-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl]-3-(methoxymethyl)pent-2-enoic acid
(1r,4ar,5s,8ar)-5-[(3e)-5-methoxy-3-methyl-5-oxopent-3-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid
(6ar,7s,8r,10as)-7-{2-[(3s,5r)-5-methoxyoxolan-3-yl]ethyl}-7,8-dimethyl-1h,5h,6h,6ah,8h,9h,10h-naphtho[4,4a-c]furan-3-one
methyl 16-isopropyl-5,9-dimethyl-13,14-dioxatetracyclo[10.2.2.0¹,¹⁰.0⁴,⁹]hexadec-15-ene-5-carboxylate
5-[(3z)-6-(methoxycarbonyl)-1,10-dimethyl-7-methylidenecyclodeca-3,5-dien-1-yl]-3-methylpentanoic acid
5-{5-[(acetyloxy)methyl]-8a-methyl-2-methylidene-octahydronaphthalen-1-yl}-3-methylpent-2-enoic acid
methyl (2z,4r)-5-[(1r,4ar,8ar)-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-formyl-4-hydroxypent-2-enoate
methyl (2e)-5-[(1s,4ar,5r,8ar)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-6-oxo-hexahydronaphthalen-1-yl]-3-methylpent-2-enoate
(2r,3r)-1-[(1r)-4-hydroxy-7-(3-methylbut-2-en-1-yl)-1,3-dihydro-2-benzofuran-1-yl]octane-2,3-diol
17alpha,20r-dihydroxypregnan-3,16-dione
{"Ingredient_id": "HBIN001986","Ingredient_name": "17alpha,20r-dihydroxypregnan-3,16-dione","Alias": "17\u03b1,20r-dihydroxypregnan-3,16-dione","Ingredient_formula": "C21H32O4","Ingredient_Smile": "CC(C1(C(=O)CC2C1(CCC3C2CCC4C3(CCC(=O)C4)C)C)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25877;6099","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}